GlobeNewswire
Lisata Therapeutics Announces Mutual Termination of License Agreement with Qilu Pharmaceutical for Certepetide
📈
AI Sentiment
Highly Positive
8/10
Latest updates and market news for LSTA
AI Sentiment
Highly Positive
8/10
AI Sentiment
Positive
7/10
AI Sentiment
Positive
6/10
Share this news page